Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Unlike the SUSTAIN-6 study, this study excluded any patients who had pre-existing proliferative diabetic retinopathy (PDR) prior to initiation of tirzepatide and matched patients with their baseline level of DR or DME
Mody R, Yu M, Nepal B, Konig M, Grabner M
Some competitors, like Hims, only offer injectable versions of these drugs, but Henry provides injections or oral versions of two of the most effective and popular GLP-1 RAs on the market
Bmj 382, e071675
Individual results vary based on starting weight, dose, adherence, and personal medical history.
US$ 21.92
US$ 22.19
US$ 26.46
&srotate=0)
US$ 25.29
US$ 27.99
